These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24087985)

  • 1. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning.
    Freycon F; Trombert-Paviot B; Casagranda L; Frappaz D; Mialou V; Armari-Alla C; Gomez F; Faure-Conter C; Plantaz D; Berger C;
    Pediatr Hematol Oncol; 2014 Apr; 31(3):225-36. PubMed ID: 24087985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of severe late-effects after 12 Gy fractionated total body irradiation and allogeneic stem cell transplantation for childhood leukemia (1988-2010).
    Freycon F; Casagranda L; Trombert-Paviot B
    Pediatr Hematol Oncol; 2019 Mar; 36(2):86-102. PubMed ID: 30978121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-course and risk factors of hypothyroidism following allogeneic hematopoietic stem cell transplantation (HSCT) in children conditioned with fractionated total body irradiation.
    Bailey HK; Kappy MS; Giller RH; Gralla J
    Pediatr Blood Cancer; 2008 Sep; 51(3):405-9. PubMed ID: 18523993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence.
    Vatanen A; Wilhelmsson M; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
    Eur J Endocrinol; 2014 Feb; 170(2):211-8. PubMed ID: 24179099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI.
    Garming-Legert K; Remberger M; Ringdén O; Hassan M; Dahllöf G
    Oral Dis; 2011 Oct; 17(7):670-6. PubMed ID: 21718391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
    Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
    J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Final height and body mass index after fractionated total body irradiation and allogeneic stem cell transplantation in childhood leukemia.
    Freycon F; Trombert-Paviot B; Casagranda L; Mialou V; Berlier P; Berger C; Armari-Alla C; Faure-Conter C; Glastre C; Langevin L; Doyen S; Stephan JL
    Pediatr Hematol Oncol; 2012 May; 29(4):313-21. PubMed ID: 22568794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucositis after reduced intensity conditioning and allogeneic stem cell transplantation.
    Busemann C; Wilfert H; Neumann T; Kiefer T; Dölken G; Krüger WH
    Onkologie; 2011; 34(10):518-24. PubMed ID: 21985850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia.
    Kobos R; Steinherz PG; Kernan NA; Prockop SE; Scaradavou A; Small TN; Shukla N; Khalaf R; O'Reilly RJ; Boulad F
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):473-80. PubMed ID: 22079789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult testicular volume predicts spermatogenetic recovery after allogeneic HSCT in childhood and adolescence.
    Wilhelmsson M; Vatanen A; Borgström B; Gustafsson B; Taskinen M; Saarinen-Pihkala UM; Winiarski J; Jahnukainen K
    Pediatr Blood Cancer; 2014 Jun; 61(6):1094-100. PubMed ID: 24851267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.
    Chen YB; Coughlin E; Kennedy KF; Alyea EP; Armand P; Attar EC; Ballen KK; Cutler C; Dey BR; Koreth J; McAfee SL; Spitzer TR; Antin JH; Soiffer RJ; Ho VT
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):981-7. PubMed ID: 23562738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].
    Niedzielska E; Wójcik D; Barg E; Pietras W; Sega-Pondel D; Doroszko A; Niedzielska M; Skarzyńska M; Chybicka A
    Med Wieku Rozwoj; 2008; 12(3):761-6. PubMed ID: 19305027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual, auditory, sensory, and motor impairments in long-term survivors of hematopoietic stem cell transplantation performed in childhood: results from the Bone Marrow Transplant Survivor study.
    Gurney JG; Ness KK; Rosenthal J; Forman SJ; Bhatia S; Baker KS
    Cancer; 2006 Mar; 106(6):1402-8. PubMed ID: 16453335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register.
    Ferry C; Ouachée M; Leblanc T; Michel G; Notz-Carrére A; Tabrizi R; Flood T; Lutz P; Fischer A; Gluckman E; Donadieu J
    Bone Marrow Transplant; 2005 Jan; 35(1):45-50. PubMed ID: 15489867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
    Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.